John L Cameron

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc One thousand consecutive pancreaticoduodenectomies
    John L Cameron
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Ann Surg 244:10-5. 2006
  2. pmc Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies
    Eric B Schneider
    Center for Surgical Trials and Outcomes Research, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    J Am Coll Surg 215:607-15. 2012
  3. pmc Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas
    Michael J Swartz
    Department of Radiation Oncology and Molecular Radiation Sciences, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Hospital, Baltimore, MD 21231 2410, USA
    Int J Radiat Oncol Biol Phys 76:839-44. 2010
  4. doi request reprint Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis
    Mechteld C de Jong
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg 252:142-8. 2010
  5. pmc Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States
    Omar Hyder
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
    JAMA Surg 148:1095-102. 2013
  6. ncbi request reprint Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer
    Michael G House
    Department of Surgery, the Indiana University School of Medicine, Indianapolis, USA
    J Gastrointest Surg 10:138-45. 2006
  7. ncbi request reprint Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression
    Steven R Hustinx
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Cancer Biol Ther 3:1254-61. 2004
  8. ncbi request reprint Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival
    Taylor S Riall
    Departments of Surgery, The Sol Goldman Pancreas Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Gastrointest Surg 9:1191-204; discussion 1204-6. 2005
  9. ncbi request reprint MKK4 status predicts survival after resection of gastric adenocarcinoma
    Steven C Cunningham
    Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21231 1000, USA
    Arch Surg 141:1095-9; discussion 1100. 2006
  10. pmc Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study
    Charles C Hsu
    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, MD, USA
    Ann Surg Oncol 17:981-90. 2010

Detail Information

Publications69

  1. pmc One thousand consecutive pancreaticoduodenectomies
    John L Cameron
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Ann Surg 244:10-5. 2006
    ..To trace the evolution of pancreaticoduodenectomy from the decade of the 1960s through the first decade of the new Millenium, through the experience of one surgeon doing 1000 consecutive operations...
  2. pmc Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies
    Eric B Schneider
    Center for Surgical Trials and Outcomes Research, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    J Am Coll Surg 215:607-15. 2012
    ..The objective of the current study was to compare readmission after pancreatic vs hepatobiliary surgical procedures, as well as to identify potential factors associated with higher readmission within 30 days of discharge...
  3. pmc Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas
    Michael J Swartz
    Department of Radiation Oncology and Molecular Radiation Sciences, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Hospital, Baltimore, MD 21231 2410, USA
    Int J Radiat Oncol Biol Phys 76:839-44. 2010
    ..Intraductal papillary mucinous neoplasms are mucin-producing cystic neoplasms of the pancreas. One-third are associated with invasive carcinoma. We examined the benefit of adjuvant chemoradiotherapy (CRT) for this cohort...
  4. doi request reprint Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis
    Mechteld C de Jong
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg 252:142-8. 2010
    ..To analyze the perioperative and long-term outcomes of patients undergoing liver-directed therapy after pancreaticoduodenectomy in a large dual-center cohort of patients...
  5. pmc Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States
    Omar Hyder
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
    JAMA Surg 148:1095-102. 2013
    ..IMPORTANCE It is not known whether hospital and surgeon volumes have an association with readmission among patients undergoing pancreatoduodenectomy...
  6. ncbi request reprint Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer
    Michael G House
    Department of Surgery, the Indiana University School of Medicine, Indianapolis, USA
    J Gastrointest Surg 10:138-45. 2006
    ..Patterns of liver metastases from islet cell tumors, specifically multiple bilobar metastases that are not amenable to resection and/or ablation, predict a poor outcome despite resection of the primary pancreatic tumor...
  7. ncbi request reprint Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression
    Steven R Hustinx
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Cancer Biol Ther 3:1254-61. 2004
    ..TAGmapper should prove to be a powerful tool for the discovery of novel tumor markers through assignment of uncharacterized SAGE tags...
  8. ncbi request reprint Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival
    Taylor S Riall
    Departments of Surgery, The Sol Goldman Pancreas Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Gastrointest Surg 9:1191-204; discussion 1204-6. 2005
    ..002)...
  9. ncbi request reprint MKK4 status predicts survival after resection of gastric adenocarcinoma
    Steven C Cunningham
    Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21231 1000, USA
    Arch Surg 141:1095-9; discussion 1100. 2006
    ..Lack of expression of the tumor-suppressor gene MKK4 is significantly correlated with poor survival after resection of gastric adenocarcinoma...
  10. pmc Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study
    Charles C Hsu
    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, MD, USA
    Ann Surg Oncol 17:981-90. 2010
    ..Our goal was to examine efficacy of adjuvant CRT in resected pancreatic adenocarcinoma compared with surgery alone...
  11. ncbi request reprint Gene expression profiling identifies markers of ampullary adenocarcinoma
    N Tjarda Van Heek
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205 2196, USA
    Cancer Biol Ther 3:651-6. 2004
    ..001). Measurement of markers of ampullary cancer such as osteopontin may aid in the early detection and differential diagnosis of patients with periampullary lesions...
  12. pmc Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas
    Norihiro Sato
    Departments of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205 2196, USA
    Am J Pathol 164:903-14. 2004
    ..0001). Our findings suggest that preoperative assessment of gene expression profiles may be able to differentiate invasive from noninvasive IPMNs...
  13. ncbi request reprint Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms
    Steven R Hustinx
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
    Cancer Biol Ther 4:596-601. 2005
    ..4; 0.9-2.2, p = 0.14). Aberrant expression of 14-3-3sigma may contribute to the outcome of patients with pancreatic ductal adenocarcinoma...
  14. ncbi request reprint Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors
    Tom C Nguyen
    Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 4606, USA
    J Gastrointest Surg 7:1-9; discussion 9-11. 2003
    ..These results imply that no negative long-term QOL measures are associated with radical pancreaticoduodenectomy (as performed in this study) for periampullary adenocarcinoma...
  15. doi request reprint Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio
    Bolanle Asiyanbola
    Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Halsted 614, Baltimore, MD 22187 6681, USA
    J Gastrointest Surg 13:752-9. 2009
    ..There are limited data on patterns of recurrence and factors associated with local recurrence following pancreaticoduodenectomy for pancreatic adenocarcinoma and adjuvant 5-flurouracil-based chemoradiation therapy...
  16. pmc Intraductal papillary mucinous neoplasms of the pancreas: an updated experience
    Taylor A Sohn
    Departments of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg 239:788-97; discussion 797-9. 2004
    ..To update the authors' experience with intraductal papillary mucinous neoplasms (IPMNs) of the pancreas...
  17. pmc Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis
    Jeffrey M Hardacre
    Department of Surgery, The Johns Hopkins Hospital, 600 N Wolfe Street, Baltimore, MD 21287 4688, USA
    Ann Surg 237:853-8; discussion 858-9. 2003
    ....
  18. pmc Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma
    David P Horowitz
    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Int J Radiat Oncol Biol Phys 80:1391-7. 2011
    ..To evaluate the efficacy of adjuvant chemoradiation therapy (CRT) for pancreatic adenocarcinoma patients ≥ 75 years of age...
  19. doi request reprint Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors
    Eric B Schneider
    Department of Surgery and Center for Surgical Trials and Outcomes Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Am Coll Surg 214:390-8; discussion 398-9. 2012
    ..The objective of the current study was to evaluate risk factors associated with readmission among a nationwide cohort of patients after colorectal surgery...
  20. pmc Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer
    Charles C Hsu
    The Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 410 North Broadway Suite 1440, Baltimore, MD 21231 2410, USA
    J Gastrointest Surg 16:753-61. 2012
    ..This study examines the preoperative predictors of early mortality following PD and combines these variables into an early mortality risk score (EMRS)...
  21. ncbi request reprint Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis
    Mark B Slidell
    Department of Surgery, Georgetown University Hospital, Washington, District of Columbia, USA
    Ann Surg Oncol 15:165-74. 2008
    ..LNR has never been investigated in a large population-based study of patients with pancreatic adenocarcinoma...
  22. pmc Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma
    Mechteld C de Jong
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Surg Oncol 103:656-62. 2011
    ..We sought to examine the association of size with outcomes following resection of pancreatic adenocarcinoma...
  23. doi request reprint Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience
    Lia Assumpcao
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Gastrointest Surg 12:1915-23. 2008
    ..We sought to identify possible risk factors associated with chyle leaks following pancreatic resection, as well as determine the natural history of this rare complication...
  24. ncbi request reprint Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies
    Christine A Iacobuzio-Donahue
    Departments of Pathology, Surgery, Oncology, and Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    Cancer Res 63:8614-22. 2003
    ....
  25. ncbi request reprint Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions
    Anil V Parwani
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland 21231 2410, USA
    Mod Pathol 16:299-308. 2003
    ..It is noteworthy that all of these alterations occur at the level of carcinoma in situ...
  26. pmc Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series
    Sushanth Reddy
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    J Am Coll Surg 208:950-7; discussion 957-9. 2009
    ..Solid-pseudopapillary neoplasms (SPNs) are rare pancreatic tumors with malignant potential. Clinicopathologic characteristics and outcomes of patients with SPN were reviewed...
  27. pmc Gallbladder cancer: the role of laparoscopy and radical resection
    Samuel P Shih
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg 245:893-901. 2007
    ..We assess how laparoscopy has altered the presentation of patients with gallbladder cancer and determine whether radical resection in patients with gallbladder cancer is beneficial...
  28. doi request reprint Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms
    Mouen A Khashab
    Department of Medicine and Division of Gastroenterology and Hepatology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    Am J Gastroenterol 106:1521-6. 2011
    ..Identification of factors associated with symptomatic or aggressive SCNs may aid management decisions. The aim of this study was to identify variables that predict aggressive SCNs...
  29. ncbi request reprint p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis
    Christophe Rosty
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    Am J Surg Pathol 27:1495-501. 2003
    ..This alteration, common to pancreatic cancer-associated PanINs, may contribute to the predisposition of patients with chronic pancreatitis to develop pancreatic ductal adenocarcinoma...
  30. pmc Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience
    Peter J Kneuertz
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Gastrointest Surg 15:1917-27. 2011
    ..We examined trends in the relative use of palliative bypass over time with an emphasis on identifying changes in surgical indications, type of bypass performed, as well as perioperative outcomes associated with surgical palliation...
  31. doi request reprint Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas
    Boris Hristov
    Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD, USA
    Int J Radiat Oncol Biol Phys 76:176-80. 2010
    ..The purpose of this study was to compare outcomes between pancreaticoduodenectomy (PD) with and without mesenterico-portal vein resection (VR) in patients receiving adjuvant CRT for pancreatic adenocarcinoma...
  32. ncbi request reprint Predicting resectability of periampullary cancer with three-dimensional computed tomography
    Michael G House
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Gastrointest Surg 8:280-8. 2004
    ....
  33. ncbi request reprint Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial
    Jordan M Winter
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Gastrointest Surg 10:1280-90; discussion 1290. 2006
    ..3). Internal pancreatic duct stenting does not decrease the frequency or the severity of postoperative pancreatic fistulas...
  34. pmc Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients
    Jason K Sicklick
    Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Ann Surg 241:786-92; discussion 793-5. 2005
    ..Three patients died without surgery due to uncontrolled sepsis. One hundred seventy-five patients underwent surgical repair, with a 1.7% postoperative mortality and a complication rate of 42.9%...
  35. ncbi request reprint Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer
    Joseph M Herman
    Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland 21231, USA
    Int J Radiat Oncol Biol Phys 86:678-85. 2013
    ..Gemcitabine-erlotinib therapy has demonstrated a survival benefit for patients with metastatic PDAC. Here we report the first phase 2 study of erlotinib in combination with adjuvant chemoradiation and chemotherapy for resected PDAC...
  36. ncbi request reprint Risk factors for pancreatic leak after distal pancreatectomy
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Ann Surg 250:277-81. 2009
    ..We sought to evaluate the incidence of and identify risk factors for the development of PL in patients undergoing distal pancreatectomy (DP) at a single high-volume institution...
  37. ncbi request reprint Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study
    Susan Tsai
    Department of Surgery, Johns Hopkins Medical Institutions, 600N Wolfe Street, Baltimore, MD 21287, USA
    J Gastrointest Surg 14:1143-50. 2010
    ..To examine the effect of body mass index (BMI) on clinicopathologic factors and long-term survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma...
  38. pmc Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients
    K Ranh Voong
    Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Hospital, Baltimore, MD 21231 6681, USA
    Hum Pathol 41:113-22. 2010
    ..Treatment with adjuvant chemoradiation therapy is associated with improved survival. The proportion of squamous differentiation in resected pancreatic adenosquamous carcinoma specimens does not appear to impact overall survival...
  39. doi request reprint Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis
    Jordan M Winter
    Department of Surgery, Johns Hopkins Medical Institutions, Halsted 610, 600 N Wolfe Street, Baltimore, MD 21287, USA
    J Gastrointest Surg 14:379-87. 2010
    ..We sought to examine the outcome of patients undergoing pancreaticoduodenectomy versus ampullectomy, as well as to identify factors predictive of lymph node metastasis in patients with ampullary neoplasms...
  40. pmc Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent
    Skye C Mayo
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Cancer 118:2674-81. 2012
    ..Survival estimates, however, are dynamic and may change based on the time already survived. The authors sought to assess conditional survival among a large cohort of patients who underwent resection of PDAC...
  41. pmc Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study
    Amol K Narang
    Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Radiat Oncol 6:126. 2011
    ..We combined the experience of two institutions to better delineate which patients may benefit from adjuvant chemoradiation...
  42. doi request reprint Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Surg Oncol 99:87-92. 2009
    ..We sought to analyze peri-operative mortality and long-term survival following TP versus PP for pancreatic adenocarcinoma...
  43. ncbi request reprint Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays
    Norihiro Sato
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205 2196, USA
    Cancer Res 63:3735-42. 2003
    ..Thus, a substantial number of genes are induced by 5Aza-dC treatment of pancreatic cancer cells, and many of them may represent novel targets for aberrant methylation in pancreatic carcinoma...
  44. ncbi request reprint Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy
    Steven R Hustinx
    Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    Cancer Biol Ther 4:83-6. 2005
    ..Thus, pancreatic cancer is a promising cancer type in which to explore novel chemotherapeutic strategies to exploit the selective loss of MTAP function...
  45. pmc Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas
    Kristin J Redmond
    Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 17:3112-9. 2010
    ..This study was designed to examine the effect of adjuvant 5-FU-based chemoradiation therapy (CRT) after distal pancreatectomy for adenocarcinoma of the distal pancreas...
  46. ncbi request reprint Pancreaticoduodenectomy in the very elderly
    Martin A Makary
    Department of Surgery, John Hopkins University School of Medicine and Bloomberg School of Public Health, Johns Hopkins Medical Institutions, 4940 Eastern Avenue, Baltimore, MD 21224, USA
    J Gastrointest Surg 10:347-56. 2006
    ..The advent of improved surgical outcomes and an aging population will likely result in a significant increase in the number of PDs performed in the next few decades...
  47. ncbi request reprint Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival
    Sushanth Reddy
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 22187, USA
    Ann Surg 250:282-7. 2009
    ..To analyze relative perioperative and long-term outcomes of patients undergoing total pancreatectomy versus pancreaticoduodenectomy...
  48. ncbi request reprint Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up
    Taylor S Riall
    Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Surgery 140:764-72. 2006
    ..Many studies have reported 5-year survival data after pancreaticoduodenectomy for periampullary adenocarcinoma. This study evaluates 10-year survival in patients surviving 5 years after initial surgery...
  49. ncbi request reprint Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases
    Epameinondas Dogeas
    Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD
    J Am Coll Surg 218:628-35. 2014
    ..In this study, we aimed to evaluate the use of ALT as a biomarker in patients with NELM, in particular to predict the site of origin of metastases...
  50. pmc Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer
    Kieran Brune
    Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
    Am J Surg Pathol 30:1067-76. 2006
    ..The multifocal nature of familial pancreatic neoplasia suggests that surveillance of these patients is warranted after partial pancreatectomy...
  51. pmc Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm?
    Jin He
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Am Coll Surg 216:657-65; discussion 665-7. 2013
    ..Little is known about the risk of subsequently developing a new or progressive intraductal papillary mucinous neoplasm (IPMN) after partial pancreatic resection of a noninvasive IPMN...
  52. doi request reprint Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning
    Haoming Qiu
    Department of Radiation Oncology and Molecular Radiation Sciences, Sol Goldman Pancreatic Cancer Research Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
    Radiother Oncol 104:167-72. 2012
    ....
  53. doi request reprint Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system
    Raghunandan Venkat
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Arch Surg 146:1277-84. 2011
    ..To develop and validate a risk score to predict the 30- and 90-day mortality after a pancreaticoduodenectomy or total pancreatectomy on the basis of preoperative risk factors in a high-volume program...
  54. pmc Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays
    Christine A Iacobuzio-Donahue
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    Am J Pathol 162:1151-62. 2003
    ..The genes and expressed sequence tags presented in this study provide clues to the pathobiology of pancreatic cancer and implicate a large number of potentially new molecular markers for the detection and treatment of pancreatic cancer...
  55. ncbi request reprint Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature
    Akhil K Seth
    Department of Surgery, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Carnegie 683, Baltimore, MD 21287, USA
    J Gastrointest Surg 12:1061-7. 2008
    ..Acinar cell carcinoma (ACC) is a rare, malignant neoplasm with a generally poor prognosis. We report our institutional series of 14 patients with ACC to determine current guidelines for their evaluation and treatment...
  56. ncbi request reprint Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Room 442, Cancer Research Building, 1650 Orleans Street, Baltimore, MD 21231 1000, USA
    J Gastrointest Surg 11:1488-96; discussion 1496-7. 2007
    ..We suggest that these trends are largely caused by developments in imaging technology, improvements in patient selection, and advances in surgical techniques...
  57. pmc Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis
    Jordan M Winter
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg 243:673-80; discussion 680-3. 2006
    ..While incidental masses in certain organs have received particular attention, periampullary and pancreatic incidentalomas (PIs) remain poorly characterized...
  58. ncbi request reprint 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
    Jordan M Winter
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Gastrointest Surg 10:1199-210; discussion 1210-1. 2006
    ..This is the largest single-institution experience with PD for pancreatic cancer. Patients who have cancers with favorable pathological features have a statistically significant improved long-term survival...
  59. pmc Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment
    George A Poultsides
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 19:1928-35. 2012
    ..Duodenal adenocarcinoma is a rare cancer usually studied as a group with periampullary or small bowel adenocarcinoma; therefore, its natural history is poorly understood...
  60. doi request reprint Pancreatic resection of isolated metastases from nonpancreatic primary cancers
    Sushanth Reddy
    Department of Surgery, The Johns Hopkins University, 600 North Wolfe Street, Carnegie 681, Baltimore, Maryland 21287, USA
    Ann Surg Oncol 15:3199-206. 2008
    ..The goal of this study is to report the safety and efficacy of pancreatic resection for isolated metastatic cancers from nonpancreatic primary disease...
  61. ncbi request reprint Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice
    Noriyoshi Fukushima
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205 2196, USA
    Cancer Biol Ther 2:78-83. 2003
    ..methylated in pancreatic secretions, detection of methylated ppENK and pi6 in pure pancreatic juice obtained by direct cannulation of the pancreatic duct to avoid duodenal secretions may suggest the presence of pancreatic adenocarcinoma..
  62. ncbi request reprint Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray
    Anirban Maitra
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Mod Pathol 16:902-12. 2003
    ....
  63. ncbi request reprint Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
    Ana Luiza Gleisner
    Department of Surgery, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 22187 6681, USA
    Cancer 110:2484-92. 2007
    ..Specifically, the role of hepatic resection for metastatic periampullary or pancreatic adenocarcinoma remains controversial...
  64. ncbi request reprint Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution
    Steven C Cunningham
    Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 1000, USA
    J Gastrointest Surg 9:718-25. 2005
    ..Many of the reported differences among Western series may be due to cohort differences, such as stage of disease, extent of resection, tumor type, and tumor location...
  65. pmc Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma
    Peter Peng
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Gastrointest Surg 16:1478-86. 2012
    ..Sarcopenia--the measurement of muscle wasting--may be a more objective and comprehensive patient-specific factor associated with long-term survival...
  66. pmc Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas
    George A Poultsides
    Department of Surgery, Sidney Kimmel Cancer Center, Johns Hopkins Hospital, Baltimore, MD, USA
    Ann Surg 251:470-6. 2010
    ....
  67. ncbi request reprint Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays
    Sharon L Swierczynski
    Department of Pathology, The Johns Hopkinds University School of Medicine, Baltimore, MD 21231, USA
    Hum Pathol 35:357-66. 2004
    ..Therefore, these markers are potentially useful in developing diagnostic tests and treatment paradigms for tumors involving the biliary system...
  68. ncbi request reprint Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags
    Dengfeng Cao
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Cancer Biol Ther 3:1081-9; discussion 1090-1. 2004
    ....
  69. pmc Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality
    Charles J Yeo
    Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Ann Surg 236:355-66; discussion 366-8. 2002
    ..To evaluate, in a prospective, randomized single-institution trial, the end points of operative morbidity, operative mortality, and survival in patients undergoing standard versus radical (extended) pancreaticoduodenectomy...